EP3681483
Aðferð fyrir frostþurrkaða lyfjasamsetningu af meðferðarprótíni
Status:
EP Einkaleyfi ógilt eftir andmæliEP appl. date:
10.9.2018EP published:
18.5.2022EP application number:
18779167.8
EP translation filed:
15.8.2022Grant published:
15.9.2022EPO information:
European Patent Register
Max expiry date:
9.9.2038Expiry date:
9.9.2026
Title in English:
PROCESS FOR LYOPHILIZED PHARMACEUTICAL FORMULATION OF A THERAPEUTIC PROTEINLanguage of the patent:
English
Timeline
Today
10.9.2018EP application
18.5.2022EP Publication
15.8.2022Translation submitted
15.9.2022Registration published
9.9.2026Expires
Owner
Name:
Amgen Inc.Address:
One Amgen Center Drive, Thousand Oaks, California 91320-1799, US
Inventor
Name:
TALLEY, CleaAddress:
Camarillo, California 93010, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201762559420 PDate:
15.9.2017Country:
US
Classification
Categories:
A61K 9/19, A61K 47/10, A61K 47/26, A61K 47/18, A61K 38/19
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 26.9.2022
Expires: 9.9.2023
Payer: Árnason Faktor ehf.
Number: 6
Paid: 15.9.2023
Expires: 9.9.2024
Payer: Árnason Faktor ehf.
Number: 7
Paid: 22.8.2024
Expires: 9.9.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 10.9.2025
Expires: 9.9.2026
Payer: Árnason Faktor ehf.